GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Other Current Liabilities

Shandong Boan Biotechnology Co (HKSE:06955) Other Current Liabilities : HK$197.0 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Other Current Liabilities?

Shandong Boan Biotechnology Co's other current liabilities for the quarter that ended in Dec. 2023 was HK$197.0 Mil.

Shandong Boan Biotechnology Co's quarterly other current liabilities declined from Dec. 2022 (HK$198.0 Mil) to Jun. 2023 (HK$-0.0 Mil) but then increased from Jun. 2023 (HK$-0.0 Mil) to Dec. 2023 (HK$197.0 Mil).

Shandong Boan Biotechnology Co's annual other current liabilities increased from Dec. 2021 (HK$80.4 Mil) to Dec. 2022 (HK$198.0 Mil) but then declined from Dec. 2022 (HK$198.0 Mil) to Dec. 2023 (HK$197.0 Mil).


Shandong Boan Biotechnology Co Other Current Liabilities Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Other Current Liabilities Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - -

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial - - - - -

Shandong Boan Biotechnology Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Shandong Boan Biotechnology Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Executives
Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li 2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines